Annual foundation for the accreditation of cellular therapy.

Active Purchase Order Awarded Last action

Contract number
HT001424P0145
Awardee
Awarding agency
Obligated
$41,580

Award facts

Opportunity
  • HT001424R0015 Solicitation number
Contract value 60% obligated
  • $41,580.00 Current, with exercised options
  • $69,300.00 Potential, with all options
Completion date 49% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
NAICS code
813920 Professional Organizations
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00002 $13,860
Exercise an Option P00001 $13,860
Original award $13,860

About this award

The Defense Health Agency awarded a purchase order to the Foundation For The Accreditation Of Cellular Therapy valued at $69,300.00 on May 10, 2024, for annual accreditation services for cellular therapy and bone marrow transplant programs across federal healthcare facilities. Performance occurs in Bethesda, Maryland, with a firm fixed price and no set-aside category. The order runs through May 9, 2029.

Quick answers

Who was awarded contract HT001424P0145?

HT001424P0145 was awarded to Foundation For The Accreditation Of Cellular Therapy by Defense Health Agency (Department of Defense) on May 10, 2024.

How much is contract HT001424P0145 worth?

The government has obligated $41,580 on HT001424P0145. Its potential value, with all options, is $69,300.

Was contract HT001424P0145 competed?

The extent of competition for HT001424P0145 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award